Dynamic contrast-enhanced MRI kinetic parameters have been investigated to assess the response to neoadjuvant chemotherapy (NAC). However, those studies have predictive value only after one or two cycles of NAC treatment and involves injection of contrast agent. Moreover, breast tumor sample is graded clinically using biopsy and is invasive. Aim of this study is to evaluate any correlation between MRE stiffness and clinical grading in breast carcinoma and if MRE can predict the response to NAC. Preliminary results show moderate correlation between MRE-derived stiffness and clinical grading in breast carcinoma patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords